Mignon Keaton

Mignon Keaton is an experienced clinical operations professional currently serving as the Director of Clinical Science and Operations at HGI Clinical since June 2025, where Mignon provides oversight of cross-functional teams and acts as a client escalation point for clinical studies. Mignon has been a consultant at Dunlin Group, LLC since May 2024, managing a Phase I cardiology gene therapy trial. Previously, Mignon held roles at ProKidney Corp. as Associate Director of Clinical Operations, overseeing two global Phase III cell therapy clinical trials, and as Senior Clinical Project Manager for a Phase III global trial in chronic kidney disease. Mignon also worked at Syneos Health as Sr. Project Manager for various Phase II and III clinical trials in central nervous system disorders. Mignon holds a PhD in Molecular Cancer Biology from Duke University and a BS in Biochemistry from The University of Southern Mississippi.